Category: Industry Reposts

Limflow, developer of the Limflow System for treatment of Chronic Limb-Threatening Ischemia (CLTI), partnered with NAMSA during this pertinent clinical study. With a dedicated focus on medical device and IVD products, NAMSA has designed and conducted trials in every area of the world to address wide-ranging client objectives. Our clinical experts are uniquely positioned to understand … Continued

Over the last decade, the pharmaceutical and medical device industries have undergone significant transformative trends and innovations. These shifts have rapidly improved efficiency and lowered costs while bringing an increased focus to personalized patient care. According to a 2019 study by Research and Markets, sales in the pharmaceutical industry are expected to rise to $900 billion in 2019 to $1.2 trillion by 2024, while the global medical device market is expected to grow at a CAGR of 5.33 percent to $521.64 billion by 2022.